Aetion
Emily Rubinstein currently holds the position of Vice President of Global Scientific Data Insights at Aetion since April 2019. Prior to that, Emily worked at Pfizer as a Senior Director of Data Strategy. Emily also served as the Vice President of Data and Research at Context Matters Inc. Emily began their career as a Research Associate at Pfizer and worked as a Field Engineer at Mueser Rutledge Consulting Engineers. Emily holds a Master of Public Health (MPH) degree in Epidemiology and Global Health from Columbia University Mailman School of Public Health and a Bachelor of Science (BS) degree in Civil Engineering from Tufts University.
Aetion
9 followers
Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on treatments, costs, and outcomes. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era.